Overall, these data indicate that the effect of Bim heterozygosity on the lymphoma development of Eμ-Myc transgenic mice is largely B lymphoid-intrinsic, without quantifiably significant compounding effects of Bim deficiency in other tissues, including their developmental niche in the bone marrow. This evidence concerns the gene BCL2L11 and lymphoma.